Not Medicare Enrolled
Dr. Roger Rosenstock, MD
Hematology & Oncology · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenstock from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenstock? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rosenstock
Dr. Roger Rosenstock is a hematology & oncology in Lake Worth, FL, with 19 years in practice. Based on federal Medicare data, Dr. Rosenstock performed 6,071 Medicare services across 1,355 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rosenstock received a total of $14,699 from 92 pharmaceutical and/or device companies across 840 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rosenstock is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 28% volume in FL$ $14,699 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,071
Medicare services
Top 28% in FL for hematology & oncology
1,355
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~320 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia | 2,180 | $6 | $20 |
| Complete blood count (CBC) with differential | 534 | $8 | $24 |
| Blood draw (venipuncture) | 506 | $8 | $12 |
| Comprehensive metabolic blood panel | 404 | $10 | $38 |
| Uric acid level test | 383 | $4 | $10 |
| Lactate dehydrogenase (enzyme) level | 382 | $6 | $15 |
| Drug injection, under skin or into muscle | 161 | $11 | $45 |
| Iron level test | 158 | $6 | $30 |
| Transferrin (iron binding protein) level | 158 | $12 | $40 |
| Ferritin level test (iron stores) | 157 | $13 | $47 |
| Infusion, normal saline solution, 250 cc | 153 | $1 | $7 |
| Office visit, established patient (30-39 min) | 147 | $99 | $150 |
| Office visit, established patient (20-29 min) | 133 | $68 | $125 |
| Office visit, established patient, complex (40-54 min) | 119 | $139 | $200 |
| Carcinoembryonic antigen (cea) protein level | 73 | $19 | $65 |
| Vitamin B-12 level test | 58 | $15 | $55 |
| Thyroid stimulating hormone (TSH) test | 58 | $16 | $32 |
| Thyroxine (thyroid chemical), total | 56 | $7 | $13 |
| Thyroid hormone evaluation | 56 | $6 | $12 |
| Folic acid level test | 50 | $14 | $32 |
| PSA test (prostate cancer screening) | 45 | $18 | $69 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 38 | $20 | $55 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $17 | $32 |
| Red blood count, manual test | 22 | $4 | $18 |
| New patient office visit, complex (60-74 min) | 14 | $170 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
38.6% medium
58.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,699
Total received (2018-2024)
Avg $2,100/year across 7 years
Top 31% in FL for hematology & oncology
92
Companies
840
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,699 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,449
2023$3,007
2022$2,377
2021$1,410
2020$1,477
2019$2,113
2018$1,866
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,056
Janssen Biotech, Inc.
$850
Novartis Pharmaceuticals Corporation
$817
Celgene Corporation
$743
E.R. Squibb & Sons, L.L.C.
$716
AstraZeneca Pharmaceuticals LP
$636
Lilly USA, LLC
$626
Seagen Inc.
$591
Merck Sharp & Dohme LLC
$430
EMD Serono, Inc.
$420
GENZYME CORPORATION
$394
Daiichi Sankyo Inc.
$381
Incyte Corporation
$371
Eisai Inc.
$364
Amgen Inc.
$350
Genentech USA, Inc.
$338
Astellas Pharma US Inc
$276
Sirtex Medical Inc
$244
Merck Sharp & Dohme Corporation
$239
JAZZ PHARMACEUTICALS INC.
$226
Takeda Pharmaceuticals U.S.A., Inc.
$221
GlaxoSmithKline, LLC.
$212
Exelixis Inc.
$189
Alexion Pharmaceuticals, Inc.
$169
Ipsen Biopharmaceuticals, Inc
$168
Regeneron Healthcare Solutions, Inc.
$150
Pharmacyclics LLC, An AbbVie Company
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
Seattle Genetics, Inc.
$135
TerSera Therapeutics LLC
$126
Puma Biotechnology, Inc.
$126
Dova Pharmaceuticals
$119
Bayer HealthCare Pharmaceuticals Inc.
$118
Deciphera Pharmaceuticals Inc.
$115
EISAI INC.
$114
Adaptive Biotechnologies Corporation
$101
PUMA BIOTECHNOLOGY, INC.
$100
Rigel Pharmaceuticals, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$83
Pharmacosmos Therapeutics Inc.
$81
AbbVie, Inc.
$79
ABBVIE INC.
$78
Aurobindo Pharma USA, Inc.
$73
ARRAY BIOPHARMA INC
$71
Kite Pharma, Inc.
$69
Sun Pharmaceutical Industries Inc.
$61
Pharmacyclics LLC, an AbbVie Company
$60
Helsinn Therapeutics (U.S.), Inc.
$55
ADC Therapeutics America, Inc.
$54
BeiGene USA, Inc.
$53
TESARO, Inc.
$52
Acceleron Pharma, Inc.
$52
AbbVie Inc.
$50
Octapharma USA, Inc.
$49
Gilead Sciences, Inc.
$49
SOBI, INC
$49
SERVIER PHARMACEUTICALS LLC
$48
TG THERAPEUTICS, INC.
$44
TG Therapeutics, Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$41
Foundation Medicine, Inc.
$37
Aveo Pharmaceuticals, Inc.
$37
Blue Earth Diagnostics Limited
$37
Taiho Oncology, Inc.
$37
Sobi, Inc
$36
Apellis Pharmaceuticals, Inc.
$36
TOLMAR Pharmaceuticals, Inc.
$35
Jazz Pharmaceuticals Inc.
$34
TAIHO ONCOLOGY, INC.
$34
Janssen Pharmaceuticals, Inc
$34
PharmaEssentia USA Corporation
$32
MEDIVATION FIELD SOLUTIONS LLC
$29
Amneal Pharmaceuticals LLC
$28
Secura Bio, Inc.
$28
Coherus Biosciences Inc.
$26
Tolmar, Inc.
$25
Acrotech Biopharma Inc.
$25
Azurity Pharmaceuticals, Inc.
$22
G1 Therapeutics, Inc.
$21
Kyowa Kirin, Inc.
$20
Stemline Therapeutics Inc.
$20
Organon LLC
$19
INSYS Therapeutics Inc
$19
Ethicon Inc.
$18
Mylan Institutional Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Advanced Accelerator Applications
$15
Karyopharm Therapeutics Inc.
$14
Dendreon Pharmaceuticals LLC
$13
ImmunoGen, Inc.
$13
Clovis Oncology, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$12
Top 3 companies account for 18.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · Alecensa · Axumin · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GILOTRIF · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Khapzory · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · SYLVANT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TEVIMBRA · TIVDAK · TUKYSA · Tazverik · Tibsovo · Turalio · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $242 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
40
Per 100K population
2.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rosenstock is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rosenstock experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Rosenstock performed 2,180 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenstock receive payments from pharmaceutical companies?
Yes. Dr. Rosenstock received a total of $14,699 from 92 companies across 840 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenstock's costs compare to other hematology & oncologys in Lake Worth?
Dr. Rosenstock's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenstock) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Lake Worth
Browse hematology & oncologys in Lake Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology